pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
ETX-636
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
ENSEM Therapeutics Inc
0 catalysts
Phase 2
EU-101
Colorectal Cancer
Eutilex Co Ltd
0 catalysts
Phase 2
EVM-14
Esophageal Squamous Cell Carcinoma (ESCC)
Everest Medicines Ltd
0 catalysts
Phase 2
EVO-756
Chronic Inducible Urticaria
← prev
page 12 of 50
next →
131
Pain89
Neurology1
$EVMNEvommune, Inc.
0 catalysts
Phase 2
EVX-01
Metastatic Melanoma
$EVAXEvaxion A/S
0 catalysts
Phase 2
EXE-346
Pouchitis
ExeGi Pharma LLC
0 catalysts
Phase 2
EXG-34217
Dyskeratosis Congenita (Zinsser-Cole-Engman Syndrome)
Elixirgen Therapeutics Inc
0 catalysts
Phase 2
EXT-608
Hypoparathyroidism
Extend Biosciences Inc
0 catalysts
Phase 2
EcoActive
Crohn's Disease (Regional Enteritis)
Ferring International Center SA
0 catalysts
Phase 2
Elixcyte
Chronic Kidney Disease (Chronic Renal Failure)
Unicocell Biomed Co Ltd
0 catalysts
Phase 2
F-652
Alcoholic Hepatitis
IL22 Receptor
Evive Biotech
0 catalysts
Phase 2
FB-102
Celiac Disease
$FBRXForte Biosciences, Inc.
0 catalysts
Phase 2
FB-825
Atopic Dermatitis (Atopic Eczema)
Oneness Biotech Co Ltd
0 catalysts
Phase 2
FB-849
Solid Tumor
1st Bio Therapeutics Inc
0 catalysts
Phase 2
FF-10502-01
Solid Tumor
Fujifilm Holdings Corp
0 catalysts
Phase 2
FGF-1
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Zhittya Genesis Medicine Inc
0 catalysts
Phase 2
FKPC-101
Metastatic Prostate Cancer
CellVax Therapeutics Inc
0 catalysts
Phase 2
FP-101
Vasomotor Symptoms of Menopause (Hot Flashes)
Fervent Pharmaceuticals LLC
0 catalysts
Phase 2
FPI-2265
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Fusion Pharmaceuticals Inc
0 catalysts
Phase 2
FWD-1802
Metastatic Breast Cancer
Shenzhen Forward Pharmaceutical Co Ltd
0 catalysts
Phase 2
Fancalen
Fanconi Anemia
Centers of Biomedical Research Network
0 catalysts
Phase 2
GC-1134A
Fabry Disease
GC Biopharma Corp
0 catalysts
Phase 2
GCC-4001
Idiopathic Inflammatory Myopathy (IIM)
$ARTVArtiva Biotherapeutics, Inc.
0 catalysts
Phase 2
GD2-SADA-177Lu-Proteus
Melanoma
Y-mAbs Therapeutics Inc
0 catalysts
Phase 2
GEOCM-04S1
Coronavirus Disease 2019 (COVID-19)
$GOVXGeoVax Labs, Inc.
0 catalysts
Phase 2
GFH-375
Colorectal Cancer
$VSTMVerastem, Inc.
0 catalysts
Phase 2
GI-102
Metastatic Melanoma
GI Innovation Co Ltd
0 catalysts
Phase 2
GIM-122
Solid Tumor
Georgiamune Inc
0 catalysts
Phase 2
GIM-531
Metastatic Melanoma
Georgiamune Inc
0 catalysts
Phase 2
GLIX-1
High-Grade Glioma
Tetragon Biosciences Ltd
0 catalysts